Navigation Links
Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance
Date:7/28/2009

ases of $2.9 million. As a percentage of sales, personnel costs decreased by 20 basis points compared to the comparable half of the prior year.

Other operating costs increased $4.5 million, or 6.4%, in the first six months of the 2009 over the same period in the prior year due to additional variable compensation accruals of $4.0 million, higher occupancy costs of $1.2 million, other operating costs of acquisitions of $1.0 million and additional bad debt expense of $1.0 million, offset by lower advertising costs of $1.2 million and $1.5 million of reductions in other overhead costs. As a percentage of sales, other operating costs decreased by 10 basis points compared to last year's second quarter.

Interest expense for the six months ended June 30, 2009 was $1.1 million less than the same period of last year due to lower variable interest rates.

Net income applicable to common stock for the six months ended June 30, 2009 increased by 25.8% to $14.6 million, or $0.46 per diluted share, compared to pro forma net income applicable to common stock of $11.6 million, or $0.37 per diluted share, in the prior year. The pro forma results for the six months ended June 30, 2008 assume that the previously described one-time, in-kind preferred stock dividend occurred and the preferred stock was converted to common stock at the beginning of the period. Net income applicable to common stock for the six months ended June 30, 2008 on a GAAP basis was $5.9 million, or $0.24 per diluted share.

Cash from operations increased by $4.5 million, or 22.2%, to $24.5 million in the second quarter of 2009, compared to the same quarter in 2008. The improvement was primarily the result of improved operating results and a $2.7 million decrease in working capital offset by a $0.3 million decrease in non-cash items. Days sales outstanding were reduced by 4 days to 48 days as of June 30, 2009 from 52 days as of June 30, 20
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Second Quarter 2009 Earnings Release Conference Call
2. Hanger Orthopedic Group, Inc. Receives Upgrade from Standard & Poors Rating Services
3. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
6. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
7. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
8. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
9. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
10. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
11. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...l symptoms, study finds , , WEDNESDAY, ...cts are among the potential problems faced by long...ted with cisplatin-based chemotherapy, a new study...n men treated for unilateral testicular cancer bet...rvey conducted from 1998 to 2002. , The researc...
(Date:11/25/2009)...4thStraightYear ,, WASHINGTON,Nov.25/PRNewswi...(LCA-GA)issuedthe 4thAnnualReportCardonLungCancer ...tthislethaldiseaseinthestateofGeorgia.LCA-GAisacha...izationdedicatedexclusivelytopatientsupportandadvo..., (Logo: http://www.newscom.com/cgi-bin/prnh/20081...
(Date:11/25/2009)...ill tumor cells, study finds , , WEDNESD...elivered in a fingernail-size implant eliminated m...The method uses polymer disks, 8.5 millimeters in ...gens and implanted under the skin to reprogram the...rsity scientists who developed the implant predict...
(Date:11/25/2009)..., the premier resource for life science careers an...ioForest™ Hotbed Campaign this morning. , ...ber 25, 2009 -- BioSpace.com, the premier resource...d the third edition of the BioForest™ Hotbed...paign is a promotional effort highlighting biotech...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...dical Solutions, Inc. (OTC Bulletin Board: IMSU), ...appointment of Craig W. Lunsman to its board,of di...irector of William,Jamieson Group, LLC, a consulti...sman will act as Chairman of the Company,s,Audit C...
...ine survey administered by the Alliance for the Pr...iagnosed with methicillin-resistant,staphylococcus...formation,on the condition at the time of diagnosi...Most respondents reported being very concerned abo...
...tCall/ - Bradmer Pharmaceuticals Inc.,a biopharmac...ommercialization of cancer therapies, announced to...ecutive Officer of the Company, will present,at th...e III trial for Neuradiab, a treatment for newly d...
...of plastic 3-D glasses and an unearthly blue multi...horror flick -- seems to leap out of the computer ...e director,s fantasy. The horror image is real. , ... of Medicine are mapping parts of the lethal bacte...
...nc. (SPOC) of Stamford, Conn., a Technogenesis Com... and Connecticut Innovations (CI), the states quas...sting and innovation development, have announced t... CI invested in SPOC through its Connecticut BioSe...
...by without progress toward universal coverage, mor...sted, and more damage is done to an already,weaken...er and the,president pro tem introduced their heal...l Californians. We had a,Republican governor and D...
Other Medicine News:Health News:Impact Medical Solutions Announces Appointment of New Director 2Health News:Impact Medical Solutions Announces Appointment of New Director 3Health News:New Survey Finds that over Half of MRSA Patients Report Having Received No Information about the Disease from Health Care Providers 2Health News:New Survey Finds that over Half of MRSA Patients Report Having Received No Information about the Disease from Health Care Providers 3Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Northwestern exposing most deadly infectious diseases in 3-D 2Health News:Northwestern exposing most deadly infectious diseases in 3-D 3Health News:Northwestern exposing most deadly infectious diseases in 3-D 4Health News:SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations 2Health News:Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California 2
(Date:11/25/2009)...eportlinker.comannouncesthatanewmarketresearchrepo...ntalDevicesMarketAnalysisandForecaststo2015 ,,...es-Dental-Devices-Market-Analysis-and-Forecasts-to...nalysisandForecaststo2015 ,, Summary ,, Th...nddatarelatingtotheUSdentaldevicesmarket.Italsooff...
(Date:11/25/2009)...rstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldev...isruptivesurgicaltreatmentsforthespine,announcedto...0,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwi...eCompany,sproductsandwillincludecommentsfrommanage...al-innumbersare1-877-407-4018fordomesticcallersand...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--HeartWareInternational,...ovideroflessinvasive,miniaturizedcirculatorysuppor...heartfailure,todayannouncedthatitisscheduledtomake...ealthCareConferenceat8:00amESTonWednesday,December...otel,December1-2. ,, AlivewebcastoftheCompany,s...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 1Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 2Antibiotics antimicrobials and antifungals in waterways 48328 1Antibiotics antimicrobials and antifungals in waterways 48328 2Andre Agassi Playing to Fight Breast Cancer Tickets on Sale NOW 21 48327 1Andre Agassi Playing to Fight Breast Cancer Tickets on Sale NOW 21 48327 2
... the , 2007 American Society of Clinical Oncology ...lder Patients with AML and in,Refractory , ALL Pat...ular interaction of Aloxi(R),with , the 5-HT3 Rece... of Glioblastoma Patients,Treated , with Multimoda...rvival Analysis of Irofulven in Second-Line HRPC,P...
... with signs of durable,disease control in advanced...7 /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today...DEM (IDD-3) melanoma vaccine clinical trial (DC-ME...lerated with evidence of,efficacy and induction of...static melanoma. , The data were presented by Merr...
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5
BD Visitec Hydrodissection Cannulas
BD Beaver Fixation Rings
BD Visitec J Shape Cannulas
BD Visiwipe Instrument Wipes
Medicine Products: